BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1375667)

  • 21. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
    Stewart AG; Cotterill T; Harris T
    Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells.
    Pierelli L; Menichella G; Scambia G; Teofili L; Iovino S; Serafini R; Benedetti Panici P; Salerno G; Rumi C; Zini G
    Bone Marrow Transplant; 1994 Jul; 14(1):23-30. PubMed ID: 7524905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of recombinant human granulocyte colony-stimulating factor on efficacy of radiation therapy in tumor-bearing rats.
    Kabaya K; Watanabe M; Kusaka M; Akahori H; Seki M; Fushiki M
    Radiat Res; 1994 Jul; 139(1):92-6. PubMed ID: 7517051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
    Shishido K; Niikura K; Akizawa T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):973-81. PubMed ID: 1722829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
    Asano S; Hirashima K; Yoshida Y; Takaku F; Miyazaki T; Omine M; Furusawa S; Abe T; Mori M; Arimori S
    Rinsho Ketsueki; 1990 Sep; 31(9):1456-62. PubMed ID: 1701008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte kinetics in neutrophilia induced by recombinant human granulocyte colony-stimulating factor in mice.
    Yamagiwa A
    Fukushima J Med Sci; 1991 Jun; 37(1):1-11. PubMed ID: 1725671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat.
    Tanaka H; Okada Y; Kawagishi M; Tokiwa T
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1199-203. PubMed ID: 2481032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Timing of administration of granulocyte colony stimulating factor after cytotoxic chemotherapy in hematological malignancies].
    Inoue T; Ota K; Ohira H; Nakao Y; Yasui Y; Furukawa Y; Yamane T; Hiyoshi M; Sasaki A; Kishida T
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):411-7. PubMed ID: 1706171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
    Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H
    Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice.
    Fukuhara N; Ohnishi N; Mori T; Ozawa A
    Tokai J Exp Clin Med; 1990 May; 15(2-3):261-2. PubMed ID: 1718058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superoxide production by neutrophils in children with malignant tumors treated with recombinant human granulocyte colony-stimulating factor.
    Iacobini M; Palumbo G; Bartolozzi S; Mondaini C; Castello M; Clerico A; Perla FM; Werner B; Digilio G
    Haematologica; 1995; 80(1):13-7. PubMed ID: 7538966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
    Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
    Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions.
    Carulli G
    Haematologica; 1997; 82(5):606-16. PubMed ID: 9407734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure.
    Akizawa T; Shishido K; Koshikawa S
    Artif Organs; 1995 Dec; 19(12):1251-7. PubMed ID: 8967884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].
    Wei HM; Li ZJ; Wang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):930-936. PubMed ID: 35680829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) could be an effective adjuvant therapy for orthopedic implant-related infections (OIRI).
    Bai X; Zhang C; Ruan D; He Q; Hou L; Li H
    Med Hypotheses; 2011 May; 76(5):703-5. PubMed ID: 21345595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.